HIV News and Research

RSS

Nanoemulsion vaccines show increasing promise

A novel technique for vaccinating against a variety of infectious diseases - using an oil-based emulsion placed in the nose, rather than needles - has proved able to produce a strong immune response against smallpox and HIV in two new studies.

27 Feb 2008

IRIS International completes study of 85 post-prostatectomy patients using investigational NADiA PSA assay

IRIS International Inc. has announced that its Iris Molecular Diagnostics (IMD) group has successfully completed a retrospective study of stored leftover serum of 85 post-prostatectomy patients, men who had their prostate removed due to prostate cancer, using its investigational NADiA (Nucleic Acid Detection ImmunoAssay) PSA Assay.

27 Feb 2008

Tenofovir gel safe for daily use over an extended period

A vaginal microbicide that incorporates an antiretroviral (ARV) drug normally used to treat people with HIV is safe for sexually active HIV-negative women to use every day over an extended period, suggest results of a clinical trial of tenofovir topical gel.

27 Feb 2008

Experimental anti-HIV gel is safe for women to use on a daily basis

An experimental anti-HIV gel is safe for women to use on a daily basis, according to researchers at the University of Alabama at Birmingham (UAB) and the University of Pittsburgh School of Medicine.

26 Feb 2008

25% of HIV infected women want to become pregnant

About one in four women who have tested positive for the human immunodeficiency virus (HIV) expect pregnancy and motherhood to be a part of their future, recent research suggests.

26 Feb 2008

Chronic disease as great a threat as terrorists

According to international experts the global threat from chronic disease is as great as the threat of terrorism and too little is being done to fight it.

25 Feb 2008

New proof-of-principle findings that thymic involution can be reversed in humans

Scientists at the Gladstone Institute of Virology and Immunology (GIVI) and the University of California, San Francisco (UCSF) have found that therapy can be used to stimulate the production of vital immune cells, called "T- cells," in adults with HIV infection.

21 Feb 2008

Researchers determine structure of protein that mutates DNA of the AIDS virus HIV-1

Understanding the structure of proteins involved in inhibiting HIV-1 infection could help in the battle against AIDS, and University of Minnesota researchers have taken a crucial step in that direction.

21 Feb 2008

Emerging-disease hotpsots mapped

An international research team has provided the first scientific evidence that deadly emerging diseases have risen steeply across the world, and has mapped the outbreaks' main sources.

21 Feb 2008

New scientific map shows Australia is not a hotspot for new diseases

An international team of scientists has warned that tropical regions are likely to become a future hotspot for new diseases; but fortunately Australia is not one of them.

21 Feb 2008

PNG black market in snake venom means over 600 die needlessly

Recent exposure by the Australian media has revealed that more than 600 people die needlessly in Papua New Guinea (PNG) from snake bites each year because corruption keeps stocks of anti-venom so low.

21 Feb 2008

Research aims to improve method of synthesizing carbon rings

A Valparaiso University chemistry professor and his students are working to develop an improved method of synthesizing carbon rings that are essential components of thousands of organic molecules used by humans.

20 Feb 2008

Most maternal deaths worldwide are preventable

A study published in PLoS Medicine this week suggests that of women who die during pregnancy and childbirth in sub-Saharan Africa, more may die from treatable infectious diseases than from conditions directly linked to pregnancy.

20 Feb 2008

Stereotypes and misinformation about HIV still commonplace in healthcare

The doctor who wouldn't come into the patient's hospital room. The neurologist who avoided eye contact. The ambulance attendant who angrily threw her bloodied gloves into the street after learning the injured patient was HIV-positive.

20 Feb 2008

Discovery of antibody that neutralizes two viruses classified as henipaviruses

In laboratory experiments, scientists at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), and their colleagues supported by the NIH National Institute of Allergy and Infectious Disease (NIAID), have discovered an antibody that neutralizes two viruses classified as henipaviruses.

18 Feb 2008

Protein found in the saliva of deer ticks prevents the HIV-1 virus from attaching to the surface of T cells

The HIV-1 virus cripples the human immune system by targeting white blood cells called T cells that form the body's first line of defense in fighting infections.

17 Feb 2008

Bush's PEPFAR at risk, says AHF

As President Bush begins a five-country tour of Africa to visit and highlight programs funded by the President's Emergency Plan for AIDS Relief (PEPFAR), the five year-old US global AIDS program which Congress created at his request, AIDS Healthcare Foundation (AHF) has cautioned the President that his legacy as a leader in the global fight against HIV and AIDS is at risk due to proposed changes in the priorities of PEPFAR that essentially cut the heart out of this lifesaving AIDS care and treatment program. PEPFAR is currently up for reauthorization by Congress.

17 Feb 2008

New control mechanism for genetic code translation discovered in bacteria

Almost all organisms, from bacteria to human beings, share the same genetic code, a group of universal instructions used to convert DNA or RNA sequences into proteins, the "building blocks" of life.

17 Feb 2008

Human growth hormone abuse raises serious health risks

Human growth hormone (HGH), when medically necessary, is a safe and effective clinical treatment for children and adults.

13 Feb 2008

Scientists find new cellular receptor for HIV

A cellular protein that helps guide immune cells to the gut has been newly identified as a target of HIV when the virus begins its assault on the body's immune system, according to researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

11 Feb 2008